ARCPOINT ANNOUNCES APPOINTMENT OF PETER KENDALL AS INTERIM CHIEF EXECUTIVE OFFICER
GREENVILLE, South Carolina, June 09, 2026 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) announces that its...
GREENVILLE, South Carolina, June 09, 2026 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) announces that its...
TORONTO, June 09, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North...
NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology...
TORONTO, June 09, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing...
AUSTIN, Texas and DURHAM, N.C., June 09, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK),...
LITTLETON, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and...
PHILADELPHIA, June 09, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company...
Vancouver, British Columbia--(Newsfile Corp. - June 10, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF)...
Strategic Acquisition: Custom Health announces the closing of the acquisition of substantially all of the operating assets of InnovativeRx US...
STOCKHOLM, June 10, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-powered skin health solutions, today...
Half of workers report rising risk of major industrial disaster'Near misses' on the rise, driven by worker stress and fatigueHalf...
CAMPBELL, Calif., June 8, 2026 /PRNewswire/ -- After a decade of consumers being overwhelmed with biometric data but lacking supportive ways...
The same clinician-approved animations from the Hx Heart app are now available online at HxHeart.com — free, instantly, with no...
UM171 Cell Therapy is conditionally approved in Europe as Zemcelpro® (dorocubicel)Securing Canadian rights to a proprietary advanced clinical-stage product candidate...
DEMENTIA RESEARCH IS SUPPORTED BY A GIFT FROM SUSAN AND CHARLES BERGHOFF FOUNDATIONMORGAN HILL, Calif., June 9, 2026 /PRNewswire/ --...
Founder Sigurjón Kristjánsson to drive industry transformation and next-stage innovation as Founder and Vice Chairman.ALPHARETTA, Ga., June 9, 2026 /PRNewswire/...
AUSTIN, Texas, June 9, 2026 /PRNewswire/ -- Across the United States, behavioral health patients are waiting hours, sometimes days, in...
VANCOUVER, BC / ACCESS Newswire / June 9, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company")...
Expansion supports Infinx's multi-cloud approach to delivering secure, workflow-integrated AI and automation for revenue cycle and patient access teams. AUSTIN,...
The three partners are proud to jointly serve as Platinum Sponsors of the 2026 BDSRA Annual Family Conference, where they...